» Articles » PMID: 33430788

A Retrospective Study of End-stage Kidney Disease Patients on Maintenance Hemodialysis with Renal Osteodystrophy-associated Fragility Fractures

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2021 Jan 12
PMID 33430788
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk factors for ESRD-related fragility fractures, explore factors affecting the prognosis of patients with such fractures, and provide information for prevention and treatment of renal osteopathy to improve the prognosis of patients.

Methods: In this retrospective case-control study, the case notes of 521 ESRD patients who received maintenance dialysis for at least 3 months were examined. Finally, 44 patients diagnosed with fragility fractures were assigned to the fragility fracture (FF) group and 192 patients were included in the control group (CG). Demographic information, underlying diseases, nutritional, bone metabolism, and renal function parameters, along with the number and causes of any deaths, were recorded for multiple statistical analysis.

Results: The FF group had increased incidences of essential hypertension and diabetes mellitus and higher serum calcium, corrected calcium, alkaline phosphatase, and hemoglobin levels. Immunoreactive parathyroid hormone (iPTH), total cholesterol (TC), and low density lipoprotein (LDL) levels were higher in the CG. Multivariate Cox regression analysis revealed that fragility fracture was an independent risk factor for all-cause mortality in ESRD patients (P < .001, RR: 4.877, 95% CI: 2.367-10.013).

Conclusions: Essential hypertension and diabetes, high serum calcium and alkaline phosphatase levels, and reduced iPTH levels were risk factors for fragility fracture in ESRD patients. Maintaining iPTH and serum TC levels may protect against fragility fractures in them. Fragility fractures may yield poor prognosis and shorter lifespan. The presence of fragility fracture was an independent predictor of all-cause death in ESRD patients.

Citing Articles

Orthopaedic fracture site and wound healing risk among end-stage renal disease patients undergoing open reduction internal fixation: A database analysis.

Hanna G, Tischler E, Mastrokostas P, Mesimer M, Bryk E, Pipitone P J Clin Orthop Trauma. 2025; 63:102946.

PMID: 40051461 PMC: 11880590. DOI: 10.1016/j.jcot.2025.102946.


Association of aberrant mineral metabolic markers with fracture risk in chronic kidney disease: a comprehensive meta-analysis.

Liu Y, Zhang Z, Fu C, Ye Z, Jin H, Yang X BMC Nephrol. 2025; 26(1):68.

PMID: 39934684 PMC: 11818153. DOI: 10.1186/s12882-025-03992-w.


Parathyroidectomy restored bone mineral density in a neglected femoral neck fracture with renal osteodystrophy: A case report.

Lin T, Lin S, Yeh K World J Clin Cases. 2024; 12(25):5761-5768.

PMID: 39247751 PMC: 11263049. DOI: 10.12998/wjcc.v12.i25.5761.


History of fragility fracture is associated with cardiovascular mortality in hemodialysis patients: the Q-Cohort study.

Haruyama N, Nakayama M, Yamada S, Tanaka S, Hiyamuta H, Taniguchi M J Bone Miner Metab. 2024; 42(2):253-263.

PMID: 38509305 DOI: 10.1007/s00774-024-01501-x.


Characteristics and complications of fracture in older adults with chronic kidney disease: a cross-sectional study.

Meng Y, Fu M, Guo J, Wang Z, Zhang Y, Hou Z J Orthop Surg Res. 2022; 17(1):377.

PMID: 35933366 PMC: 9357309. DOI: 10.1186/s13018-022-03253-8.

References
1.
Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M . Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002; 91(1):103-11. DOI: 10.1159/000057611. View

2.
Shantouf R, Kovesdy C, Kim Y, Ahmadi N, Luna A, Luna C . Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009; 4(6):1106-14. PMC: 2689878. DOI: 10.2215/CJN.06091108. View

3.
Damasiewicz M, Nickolas T . Rethinking Bone Disease in Kidney Disease. JBMR Plus. 2018; 2(6):309-322. PMC: 6237213. DOI: 10.1002/jbm4.10117. View

4.
Tseng C, Huang W, Li T, Chen H, Muo C, Kao C . Increased risk of end-stage renal disease among hip fracture patients. Eur J Intern Med. 2014; 25(10):956-61. DOI: 10.1016/j.ejim.2014.10.017. View

5.
Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T . Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999; 33(2):287-93. DOI: 10.1016/s0272-6386(99)70302-1. View